![On the 11th (local time), Danish health authorities temporarily stopped vaccination against AstraZeneca.[AFP=연합뉴스]](https://i0.wp.com/pds.joins.com/news/component/htmlphoto_mmdata/202103/11/c3623391-5631-4fa3-a160-11d6f6fad1e3.jpg?w=560&ssl=1)
On the 11th (local time), Danish health authorities temporarily stopped vaccination against AstraZeneca.[AFP=연합뉴스]
Danish health officials have temporarily stopped vaccination for Corona 19 jointly developed by AstraZeneca (AZ) and Oxford University, the British BBC reported on the 11th (local time). This is because some cases of blood clotting among vaccinations were found. This has increased the number of European countries with partial or temporary suspension of AstraZeneca vaccination to six.
Danish health authorities said in a statement that day, “Severe cases of blood clots were reported among those who received the AstraZeneca vaccine, and the vaccination was temporarily stopped.” However, he added, “the correlation between vaccine and blood clot formation has not been confirmed.” Denmark will first stop using the AstraZeneca vaccine over the next 14 days.
The Danish action was linked to a case in which a 49-year-old female nurse previously vaccinated with AstraZeneca in Austria died from a blood clot-forming reaction. On this day, Austria stopped some of the AstraZeneca vaccines that had certain manufacturing units attached. In addition, Danish health authorities temporarily suspended the AstraZeneca vaccination when a case of blood clot formation occurred in their country. In addition, Estonia, Latvia, Lithuania and Luxembourg have partially or temporarily suspended AstraZeneca vaccination.
AstraZeneca’s position is that there is no problem with the safety of its vaccine. “Patient safety is the company’s top priority,” AstraZeneca spokesperson said. “The AstraZeneca vaccine has been tested extensively for safety issues in clinical trials and has been approved for use in accordance with regulatory requirements and safety standards.” .
European regulators, the European Medicines Agency (EMA), said, “We are reviewing cases of death in Austria, but there are currently no indications that the vaccine has caused these side effects. The EMA added that “thromboembolism (the proportion of) experienced by those who received the vaccination was less than that of the general population (the thromboembolic rate of that).”
The BBC said, “Of the 3 million people who received the AstraZeneca vaccine in Europe, there were 22 cases of blood clots (established by EMA as of the 9th). “Severe side effects are rare in humans.”
Reporter Jeong Eun-hye [email protected]
